Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remune vs IFA in HIV patients discontinuing HAART
NCT00005001Phase 2Completed
- Sponsor
- Agouron Pharmaceuticals
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Remune in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Agouron Pharmaceuticals. Primary endpoint: Plasma HIV-1 RNA Level at Day 42. Status: completed.
02
Drugs
Remune
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005001.